Results 111 to 120 of about 40,048 (221)

Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients

open access: yes, 2013
The use of linezolid for the treatment of multidrug-resistant tuberculosis is limited by dose-and time-dependent toxicity. Recently, we reported a case of pharmacokinetic drug drug interaction between linezolid and clarithromycin that resulted in ...
van Altena, Richard   +8 more
core   +1 more source

Acute pancreatitis after a course of clarithromycin.

open access: yes, 2003
We present a case of acute pancreatitis after a course of clarithromycin. An 84-year-old woman died of suspected pneumonia and cardiac failure. Autopsy surprisingly revealed acute pancreatitis.
Deinum, J., Schouwenberg, B.J.J.W.
core  

Pulse Clarithromycin Therapy In Severe ACNE Vulgaris

open access: yes, 2002
Three patients with severe acne vulgaris, not responding with long courses of doxycycline, minocycline and erythromycin were given oral clarithromycin in pulsed regimen. The patients were given 7 days course of clarithromycin 250mg twice daily, which was
Rathi Sanjay K
core  

Gene mutations related to clarithromycin resistance.

open access: yes, 2016
Gene mutations related to clarithromycin resistance.
Yoshio Yamaoka (187580)   +23 more
core   +1 more source

Ethambutol potentiates extracellular and intracellular activities of clarithromycin, sparfloxacin, amikacin, and rifampin againstMycobacterium avium

open access: yes, 1993
International audienceIntracellular bactericidal activities of the antituberculosis drugs rifampin and amikacin, as well as those of newly described drugs clarithromycin (a macrolide) and sparfoxacin (a difluoroquinolone), were assessed against three ...
Carvalho de Sousa, Joao Paulo   +2 more
core   +1 more source

Bismuth-Based Quadruple Therapy as First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Prospective Randomized Comparison of 7- and 14-Day Treatment Regimens

open access: yesGut and Liver
Background/Aims: Bismuth-based quadruple therapy (BQT) is a treatment option for clarithromycin-resistant Helicobacter pylori (HP) infection. The aim of this study was to compare the efficacy of 7-day BQT with that of 14-day BQT as first-line treatment ...
Chul-Hyun Lim, Jung-Hwan Oh
doaj   +1 more source

Exploring the Molecular Mechanisms of Macrolide Resistance in Laboratory Mutant Helicobacter pylori

open access: yesAntibiotics
Resistance to clarithromycin, a macrolide antibiotic used in the first-line treatment of Helicobacter pylori infection, is the most important cause of treatment failure. Although most cases of clarithromycin resistance in H.
Meltem Ayaş   +4 more
doaj   +1 more source

The helicobacter pylori resistance rate to clarithromycin in Iran

open access: yes, 2015
Background: Clarithromycin is the most commonly suggested antibiotic in Helicobacter pylori eradication regimens. Increasing antibiotic resistance rate to clarithromycin is the main reason for therapeutic failure.
Keshavarz Azizi Raftar, S.   +7 more
core  

Clinical Observation on Different Triple Regimens Therapy for Eradication of Helicobacter Pylori Infection

open access: yesHuli yanjiu, 2003
Objective: to observe the eradication efficacy of different triple regimens of either rabeprazole, clarithromycin plus amoxycillin or omeprazole, clarithromycin plus amoxycillin on curing patients with helicobacter pylori (Hp) infection, Hp related ...
霍丽娟
doaj  

Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin‐susceptible and clarithromycin‐resistant Helicobacter pylori strains in gastric biopsies from children

open access: yes, 2002
Aim: To compare the results of culture and epsilometer test with fluorescence in situ hybridization for the detection of Helicobacter pylori and the presence of clarithromycin-susceptible and clarithromycin-resistant strains in antral biopsies from ...
H. Rüssmann   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy